Neurocysticercosis
Information
- Disease name
- Neurocysticercosis
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03834337 | Completed | Treatment of Patients With Active Neurocysticercosis in Eastern Africa | April 1, 2019 | January 31, 2022 | |
| NCT00283699 | Completed | Phase 3 | A Pilot Study of Neurocysticercosis Treatment | February 2001 | February 2005 |
| NCT00290823 | Completed | Phase 3 | Corticosteroids to Reduce Frequency of Seizures in Neurocysticercosis Patients | April 2006 | March 2011 |
| NCT00441285 | Completed | Phase 2/Phase 3 | Neurocysticercosis: Combined Treatment With Praziquantel (PZQ) and Albendazole (ABZ) | January 2010 | September 2013 |
| NCT00526916 | Completed | Phase 1 | PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [C-11]PBR28 | September 4, 2007 | September 5, 2014 |
| NCT00527579 | Completed | Phase 1 | PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Neurocysticercosis Using [F-18]FB | September 4, 2007 | November 26, 2013 |
| NCT03874689 | Completed | Investigation of Environmental Factors Associated With Transmission of T. Solium in Endemic Villages of Zambia | June 1, 2019 | December 31, 2022 | |
| NCT02234570 | Completed | Phase 1 | Phase I Trial Evaluating the Safety and Pharmacokinetics of Oxfendazole | November 17, 2014 | November 24, 2015 |
| NCT02243644 | Completed | Phase 3 | Effects of 2 Different Duration of Albendazole Therapy in Patients With Neurocysticercosis in Brain ≤ 5 Lesions on CT | March 2014 | October 2015 |
| NCT03851419 | Completed | The Burden of (Neuro)Cysticercosis Among People Living With HIV in Rural Tanzania | April 1, 2018 | April 30, 2021 | |
| NCT06376396 | Not yet recruiting | Phase 4 | Assessment of Combined Praziquantel and Albendazole vs Albendazole Alone to Treat Active Parenchymal Neurocysticercosis | June 2024 | December 2026 |
| NCT04706819 | Not yet recruiting | Parenchymal and Extraparenchymal Neurocysticercosis-A Registry Based Study | January 15, 2021 | December 31, 2025 | |
| NCT00001205 | Recruiting | Natural History of Treated Neurocysticercosis and Long-Term Outcomes | October 7, 1985 | ||
| NCT02945527 | Terminated | Phase 2/Phase 3 | Treatment of Peri-calcification Edema in Neurocysticercosis (NCC) | December 4, 2015 | December 2018 |
| NCT02233855 | Terminated | People Presenting With Neurocysticercosis in North America | September 3, 2014 | June 13, 2017 | |
| NCT02947581 | Terminated | Phase 3 | Sub Arachnoid Neurocysticercosis Treatment Outcome (SANTO) | November 14, 2016 | February 27, 2021 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D020019